4//SEC Filing
Khayal Tamer I 4
Accession 0000950170-25-004192
CIK 0001756262other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:29 PM ET
Size
22.4 KB
Accession
0000950170-25-004192
Insider Transaction Report
Form 4
Khayal Tamer I
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-07$80.05/sh−1,083$86,694→ 20,843 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-01-07−1,083→ 15,167 totalExercise: $13.28Exp: 2032-02-22→ Common Stock (1,083 underlying) - Exercise/Conversion
Common Stock
2025-01-07$13.28/sh+1,083$14,382→ 21,926 total
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $80.00 to $80.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.
Documents
Issuer
TransMedics Group, Inc.
CIK 0001756262
Entity typeother
Related Parties
1- filerCIK 0001430462
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:29 PM ET
- Size
- 22.4 KB